Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine
Joint Authors
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-02-05
Country of Publication
Egypt
No. of Pages
9
Abstract EN
Major cardiovascular events including myocardial infarction (MI) continue to dominate morbidity rates in the developed world.
Although multiple device therapies and various pharmacological agents have been shown to improve patient care and reduce mortality rates, clinicians and researchers alike still lack a true panacea to regenerate damaged cardiac tissue.
Over the previous two to three decades, cardiovascular stem cell therapies have held great promise.
Several stem cell-based approaches have now been shown to improve ventricular function and are documented in preclinical animal models as well as phase I and phase II clinical trials.
More recently, the cardiac progenitor cell has begun to gain momentum as an ideal candidate for stem cell therapy in heart disease.
Here, we will highlight the most recent advances in cardiac stem/progenitor cell biology in regard to both the basics and applied settings.
American Psychological Association (APA)
Witman, Nevin& Sahara, Makoto. 2018. Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine. Stem Cells International،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1213599
Modern Language Association (MLA)
Witman, Nevin& Sahara, Makoto. Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine. Stem Cells International No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1213599
American Medical Association (AMA)
Witman, Nevin& Sahara, Makoto. Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine. Stem Cells International. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1213599
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1213599